EGFR and non-small cell lung carcinoma: Although multiple gene mutations, including EGFR, KRAS, p53, and PTEN, have been extensively reported in NSCLC3 comprehensive molecular mechanisms that underlie the initiation, progression, and metastasis of NSCLC remain elusive.